As of 10-15 years ago, canine lymphoma was primarily considered to be a monolithic disease with two main subtypes – high grade B-cell and T-cell lymphoma. In veterinary school, it was taught that “B is bad, but T is terrible.” Over time, this view has changed. Diffuse large B-cell lymphoma and peripheral T-cell lymphoma remain the two predominant subtypes, but we’ve come to recognize a population of more indolent lymphoid malignancies that share a slower clinical course.
![](https://metrovet-d676.kxcdn.com/wp-content/plugins/responsive-flipbook/assets/images/loader.gif)
![](https://metrovet-d676.kxcdn.com/wp-content/uploads/2023/05/SpringNewsletter_2023_001.jpg)
![](https://metrovet-d676.kxcdn.com/wp-content/plugins/responsive-flipbook/assets/images/loader.gif)
![](https://metrovet-d676.kxcdn.com/wp-content/uploads/2023/05/SpringNewsletter_2023_002.jpg)
![](https://metrovet-d676.kxcdn.com/wp-content/plugins/responsive-flipbook/assets/images/loader.gif)
![](https://metrovet-d676.kxcdn.com/wp-content/uploads/2023/05/SpringNewsletter_2023_003.jpg)
![](https://metrovet-d676.kxcdn.com/wp-content/plugins/responsive-flipbook/assets/images/loader.gif)
![](https://metrovet-d676.kxcdn.com/wp-content/uploads/2023/05/SpringNewsletter_2023_004.jpg)